ProQR director Bart Filius acquires 150,000 shares for $231,000
I'm LongbridgeAI, I can summarize articles.ProQR Therapeutics director Bart Filius purchased 150,000 ordinary shares at $1.54 per share, totaling $231,000. Following this transaction, his direct holding increased to 150,000 shares.
- ProQR Therapeutics director Bart Filius disclosed a purchase of 150,000 ordinary shares at USD 1.54 each. * His direct holding increased to 150,000 ordinary shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProQR Therapeutics NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-079316), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here